Related Experiment Video
Updated: Sep 7, 2025
07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
3.7K
Redo Robotic Partial Nephrectomy for Recurrent Renal Tumors: A Multi-Institutional Analysis.
Alp Tuna Beksac1, Umberto Carbonara2, Mahmoud Abou Zeinab1
1Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Journal of Endourology
|June 22, 2022
Summary
Robot-assisted partial nephrectomy (RAPN) effectively treats recurrent kidney masses after prior surgeries. This approach shows good outcomes and kidney function preservation, though distant recurrence requires monitoring.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- Robot-assisted partial nephrectomy (RAPN) is increasingly used for recurrent renal masses.
- Previous ipsilateral kidney surgeries present unique challenges for re-operation.
Purpose of the Study:
- To evaluate the outcomes of redo RAPN for recurrent renal masses.
- To assess perioperative and functional results in a multi-institutional series.
Main Methods:
- Retrospective analysis of 72 patients undergoing redo RAPN (2010-2020).
- Exclusion of familial renal cell carcinoma and multiple tumors.
- Data collection on demographics, tumor characteristics, and outcomes; major complications defined by Clavien grade ≥3.
Main Results:
- RAPN completed in all cases with a 2.8% conversion to open surgery rate.
- Major complication rate was 8.3%, transfusion rate 5.9%, and positive surgical margin rate 8.3%.
- Estimated glomerular filtration rate preservation was 78.7% at discharge and 90.8% at 1-year; local recurrence was 1.4%.
Conclusions:
- Redo RAPN is a viable option for select recurrent renal masses in experienced hands.
- The procedure demonstrates favorable perioperative and functional outcomes.
- Careful patient monitoring for distant recurrence is essential post-operatively.
